Can you say "cure" in Indian pharma promotional material?

Which instrument governs this

Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Section 3(d) read with the Schedule, and Section 4. They apply to any advertisement for a drug, subject to the savings in Section 14 and exemptions under Section 15. Section 14(c) of that Act saves an advertisement 'sent confidentially in the manner prescribed under section 16 only to a registered medical practitioner'. Also the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clauses 1.2, 1.3 and 2.1. The manufacturing licence conditions in the Drugs and Cosmetics Rules 1945 also apply to Schedule H, H1 and X drugs (for example Rules 74(p) and 78(q)). The conditions say no advertisement of those drugs 'shall be made except with the previous sanction of the Central Government'. Their text sets no audience limit. How they apply to material addressed only to prescribers is a question for your regulatory team.

UCPMP 2024 does not name this word. For a disease in the Schedule to the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, evidence does not lift the Section 3(d) bar. Where Section 3(d) does not apply, Section 4 still bars false or misleading claims in an advertisement the Act covers. Under the Code, the claim must also be consistent with the marketing approval and capable of substantiation.

What verification returned

Section 3(d) of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 is the first test for this word. Under it, no advertisement may suggest a drug for the diagnosis, cure, mitigation, treatment or prevention of certain conditions. They are the diseases, disorders and conditions specified in the Act's Schedule or in rules under it. That bar is subject to the savings in Section 14 and exemptions under Section 15. In our reading, replacing 'cure' with 'treats' does not fix it. The Act covers doctor-directed material too, but Section 14(c) saves an advertisement 'sent confidentially in the manner prescribed under section 16 only to a registered medical practitioner'. Where Section 3(d) does not apply, the Act still bars false or misleading claims (Section 4). An unqualified 'cure' claim has to be tested against that. The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 does not ban the word. Under the Code, the claim must still be consistent with the marketing approval (Clause 1.2). It must not mislead and must be capable of substantiation (Clause 1.3). The manufacturing licence conditions in the Drugs and Cosmetics Rules 1945 add a condition for Schedule H, H1 and X drugs (for example Rules 74(p) and 78(q)). They say no advertisement of those drugs 'shall be made except with the previous sanction of the Central Government'. Their text sets no audience limit. How they apply to material addressed only to prescribers is a question for your regulatory team. Prefer specific outcomes consistent with the marketing approval, such as 'indicated for ...' or 'achieves sustained virological response', over absolute 'cure' language.

How this was checked

Two independent AI models were asked the same question against the live web. They were Gemini 2.5 Pro with Google Search grounding, and OpenAI GPT-5 with web search. A third model then judged whether they agreed on the substance rather than the wording. Every source cited was fetched over HTTP to confirm it exists. A fetch confirms only that a source exists. It does not confirm that the source supports the statement. So on 6 October 2026 the citations on this page were re-checked. They were checked against the official texts of the Code, the Drugs and Magic Remedies Act and the CDSCO 2016 consolidated text of the Drugs Rules. They were corrected where they were wrong. Terms that did not reach agreement between the models are not published.

Sources checked

• UCPMP 2024 important documents page, Department of Pharmaceuticals
• UCPMP 2024, Department of Pharmaceuticals (PDF)
• Drugs and Magic Remedies Act 1954, consolidated text on thc.nic.in (PDF)
• Drugs and Cosmetics Act 1940 and Rules 1945, CDSCO consolidated text (PDF)